Literature DB >> 13804543

Autoantibodies in human ulcerative colitis.

O BROBERGER, P PERLMANN.   

Abstract

Sera from 30 children, suffering from ulcerative colitis, were examined for the presence of antibodies capable of reacting with antigens of normal human tissue. It was possible to demonstrate that most of the sera contained a precipitating and hemagglutinating factor, reacting with a constituent of human colonic tissue. This constituent was obtained, within 1 hour after death, from colonic tissue of newborn babies who had died without feeding. It could also be prepared from fetal tissue. The antigen can be extracted with phenol-water at 65 degrees C. and seems to be a polysaccharide. The precipitating factor in the sera of the patients behaves electrophoretically as a gamma-globulin. Phenol-water extracts from liver and from kidney also reacted positively with the sera from certain patients. There are indications which suggest that the antigen obtained from these tissues is identical with that from colon. Sera from 38 healthy children did not give any reactions with the extracts used. In additional controls, the sera of 32 children with various diseases, all of suspected autoimmune origin, were also tested. A few of these reacted positively with the phenol-water extracts from the organs mentioned above. Most likely, the antigen reacting in these cases is different from that reacting with the antibodies in the sera from patients with ulcerative colitis. The possible role of the antibodies in the pathogenesis of ulcerative colitis and the mechanism of their formation are discussed.

Entities:  

Keywords:  COLITIS, ULCERATIVE/immunology

Mesh:

Substances:

Year:  1959        PMID: 13804543      PMCID: PMC2137024          DOI: 10.1084/jem.110.5.657

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  41 in total

1.  Immunochemical studies on blood groups. XXII. Immunochemical studies on the nondialyzable residue from partially hydrolyzed blood group A, B and O(H) substances (P1 fractions).

Authors:  P Z ALLEN; E A KABAT
Journal:  J Immunol       Date:  1959-04       Impact factor: 5.422

2.  Human autoimmune thyroiditis: serological studies.

Authors:  I M ROITT; D DONIACH
Journal:  Lancet       Date:  1958-11-15       Impact factor: 79.321

3.  Hepatitis, colitis, and lupus manifestations.

Authors:  N GRAY; I R MACKAY; L I TAFT; S WEIDEN; I J WOOD
Journal:  Am J Dig Dis       Date:  1958-07

4.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

5.  The relationship of chronic ulcerative colitis and cirrhosis.

Authors:  F W HOFFBAUER; J S McCARTNEY; C DENNIS; K KARLSON
Journal:  Ann Intern Med       Date:  1953-08       Impact factor: 25.391

6.  The pathogenesis and treatment of ulcerative colitis.

Authors:  N SVARTZ
Journal:  Acta Med Scand       Date:  1951-12-12

7.  Studies of lysozyme in ulcerative colitis.

Authors:  S J GRAY; R W REIFENSTEIN; E P CONNOLLY; H M SPIRO; J C G YOUNG
Journal:  Gastroenterology       Date:  1950-12       Impact factor: 22.682

8.  Studies on organ specificity. V. Changes in the thyroid glands of rabbits following active immunization with rabbit thyroid extracts.

Authors:  N R ROSE; E WITEBSKY
Journal:  J Immunol       Date:  1956-06       Impact factor: 5.422

9.  Aspermatogenesis, anaphylaxis, and cutaneous sensitization induced in the guinea pig by homologous testicular extract.

Authors:  J FREUND; G E THOMPSON; M M LIPTON
Journal:  J Exp Med       Date:  1955-06-01       Impact factor: 14.307

10.  Specific serum agglutination of erythrocytes sensitized with extracts of tubercle bacilli.

Authors:  G MIDDLEBROOK; R J DUBOS
Journal:  J Exp Med       Date:  1948-11       Impact factor: 14.307

View more
  121 in total

1.  Historical origins of current IBD concepts.

Authors:  J B Kirsner
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

3.  OBSERVATIONS ON HUMAN COLONIC CELLULAR SUSPENSIONS AND FILTRATES AS ETIOLOGIC AGENTS IN ULCERATIVE COLITIS.

Authors:  C A HARDIN; M E VANCIL; A A WERDER; C SCHMIDT
Journal:  Am J Dig Dis       Date:  1964-08

4.  AUTO-IMMUNITY TO PROSTATE ANTIGEN IN RHEUMATIC DISEASE.

Authors:  A GRIMBLE
Journal:  J Clin Pathol       Date:  1964-05       Impact factor: 3.411

5.  Incidence of haemagglutinating and complement-fixing antibodies.

Authors:  G L ASHERSON; O BROBERGER
Journal:  Br Med J       Date:  1961-05-20

6.  THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS.

Authors:  F C EDWARDS; S C TRUELOVE
Journal:  Gut       Date:  1964-02       Impact factor: 23.059

7.  ACTIVE 'JUVENILE' CIRRHOSIS CONSIDERED AS PART OF A SYSTEMIC DISEASE AND THE EFFECT OF CORTICOSTEROID THERAPY.

Authors:  A E READ; S SHERLOCK; C V HARRISON
Journal:  Gut       Date:  1963-12       Impact factor: 23.059

8.  SERUM COMPLEMENT LEVELS IN ACTIVE ULCERATIVE COLITIS.

Authors:  J FLETCHER
Journal:  Gut       Date:  1965-04       Impact factor: 23.059

9.  [Varying influence of increased enteral antigen absorption on the behavior of "natural" antibodies in O and A blood group subjects. Comparative blood group serological studies on patients with ulcerative colitis and healthy persons].

Authors:  P Arend; G Fehlhaber
Journal:  Klin Wochenschr       Date:  1969-05-15

Review 10.  Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes.

Authors:  Altin Gjymishka; Roxana M Coman; Todd M Brusko; Sarah C Glover
Journal:  Immunotherapy       Date:  2013-12       Impact factor: 4.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.